Massive Controversy As Jon Jones’ Comeback Moved From Vegas To LA

Jon Jones weighing in before UFC 182 in 2015

Modal Trigger Jon Jones weighing in before UFC 182 in 2015. Getty Images

UFC 232 will be moved from Las Vegas to The Forum in Inglewood, California, after a trace amount of the banned substance turinabol was discovered in a drug test administered to Jon Jones on December 9.

White said Jones did nothing wrong in this instance, and the title fight needs to happen without further delay.

The decision to move the event was because Jon Jones (22-1, 1 NC), who is facing Alexander Gustafsson (18-4) for the light heavyweight title in the main event, tested positive for trace amounts of turinabol, the same substance he tested positive for previous year.

The UFC's head of athlete health and performance Jeff Novitzky said that Jones had not breached any anti-doping protocols.

The Nevada State Athletic Commission would not grant Jones a license, so to keep him on the card, the UFC moved the event to Los Angeles. "He's been cleared to fight in terms of the USADA program", Novitzky said. "We are confident after consideration of all the evidence and based on science that the resolution of this result under the UFC Anti-Doping Policy is consistent with USADA's mandate and in the interests of justice".

That's according to UFC president Dana White, who told ESPN's SportsCenter that the 31-year-old American had not been granted a license from the Nevada State Athletic Commission (NSAC). The parent compound is not approved for human use anywhere in the world ... but what both USADA and other entities are seeing is that a recurrence, or potential "pulsing, ' where you have multiple negative tests and then a positive one for a very low amount - they're seeing that quite commonly over time".

And former UFC fighter David Michaud tweeted to suggest that any trips involving a Jon Jones fight should always include contingency plans. "He's in fight shape, and I believe that he's been doing the right thing".

A urine sample on December 9 found an abnormal level of the steroid turinabol, which Jones failed a test for in 2017 after beating Daniel Cormier by knock-out. Unfortunately, this bout was quickly ruled a no contest when it was announced Jones had failed a drug test.

But as the positive result came via an out-of-competition test it did not lead to a suspension.

Latest News